Skip to main content

Market Overview

Why Avalon Globocare's Stock Is Trading Higher Today

Why Avalon Globocare's Stock Is Trading Higher Today
  • Avalon Globocare (NASDAQ: AVCO) shares are trading higher on Wednesday after the company announced the commercialization and distribution agreement with Cellex for the coronavirus antibody rapid test kit.
  • Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promote and empower high impact, transformative biotechnology, and their clinical applications, and healthcare facility management. It has two reportable segments: real property operating segment which is the key revenue driver; medical-related consulting services segment; and development services and sales of developed products segment.
  • The company focuses on the diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
  • Avalon Globocare's stock was trading up 14.82% to $1.82 per share at the time of publication on Wednesday. The stock has a 52-week high of $2.65 and a 52-week low of 50 cents.

Related Articles (AVCO)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Penny Stocks Health Care General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at